ACLX Stock Analysis: Buy, Sell, or Hold?
ACLX - Arcellx, Inc. Common Stock
$115.07
0.04 (0.03%)
▲
5d:
+0.06%
30d:
+0.39%
90d:
+67.86%
BUY
MODERATE Confidence
Analysis Updated: Apr 27, 2026 12:00 AM ET
Earnings: May 14, 2026
0d
Get Alerted When ACLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ACLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ACLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ACLX is currently trading at $115.07, which is considered fair based on recent price action.
Technical Outlook: Technically, ACLX is in a strong uptrend. The price is currently testing key support at $114.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ACLX is in a strong uptrend. The price is currently testing key support at $114.86. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
57/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Protect Your Profits
ACLX is technically overbought (RSI 79). Consider hedging now to protect against a potential pullback while keeping your upside.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($112.85)
Support & Resistance Levels
Support Level
$114.86
Resistance Level
$115.13
Current Trend
Strong Uptrend
Technical data as of
Apr 27, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-66.43
Wall Street Target
$112.85
(-1.9%)
Revenue Growth (YoY)
-89.2%
Share & Embed Analysis
Last updated: June 03, 2026 10:26 PM ET
Data refreshes hourly during market hours. Next update: 11:26 PM
Data refreshes hourly during market hours. Next update: 11:26 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ACLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Rami Elghandour
SELL
89916 shares
2026-02-27
Christopher Heery
SELL
5882 shares
2026-01-14
Christopher Heery
SELL
7437 shares
2026-01-13
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 54 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 53 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$270 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$108 | 56 HOLD |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$83 | 51 HOLD |
Advanced ACLX Option Strategies
Professional options setups generated by AI based on today's ACLX price and gamma walls.
